Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPI-MULTIBASKET trial in advanced ocular melanoma
2010-021946-22Phase 2Completed
- Sponsor
- Universitätsmedizin Essen
- Start
- Oct 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ipilimumab in intraocular melanoma and melanoma, sponsored by Universitätsmedizin Essen. Primary endpoint: Primary Objective. Started Oct 2010; status: completed.
02
Drugs
ipilimumab
03
Conditions
intraocular melanomamelanoma
Beyond the preview
Go deeper on 2010-021946-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021946-22.